Literature DB >> 28364600

MiR-370 functions as oncogene in melanoma by direct targeting pyruvate dehydrogenase B.

Shufang Wei1, Weiyuan Ma2.   

Abstract

BACKGROUND: Accumulating evidence has shown that miR-370 play an important role in the development and progression of tumor. However, the role of miR-370 in melanoma remains largely unknown. The present study is designed to investigate the function of miR-370 in melanoma and to explore the molecular mechanism underlying its function.
MATERIALS AND METHODS: The expression level of miR-370 was detected in melanoma tissues and cell lines by real-time quantitative polymerase chain reaction (qRT-PCR). The effect of overexpression of miR-370 on in vitro cell proliferation, apoptosis, invasion as well as glyclolysis was examined. Western blotting analysis was used to detect the influence of miR-370 on the expression of target genes, and Pearson analysis was used to calculate the correlation between the expression of targets gene and miR-370 in melanoma tissues.
RESULTS: Our study showed that miR-370 was upregulated in melanoma tissues compared with non-cancerous tissues (P<0.01). In addition, the expression of miR-370 in melanoma cell lines was also significantly higher (P<0.01). Enforced expression of miR-370 promotes melanoma cell proliferation, inhibits apoptosis and enhances invasion and glycolysis and led to downregulation of the PDHB protein. Moreover, the expression level of miR-370 in melanoma tissues showed inverse relationship with the expression level of PDHB protein.
CONCLUSIONS: In conclusion, our findings suggested that miR-370 represents a potential oncogenic miRNA and plays an important role in melanoma progression by directly targeting PDHB.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Melanoma; MiR-370; PDHB

Mesh:

Substances:

Year:  2017        PMID: 28364600     DOI: 10.1016/j.biopha.2017.03.068

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  10 in total

1.  Reduced Levels of miR-28 and miR-200a Act as Predictor Biomarkers of Aggressive Clinicopathological Characteristics in Gastric Cancer Patients.

Authors:  Farhad Jeddi; Shahriar Alipour; Nowruz Najafzadeh; Mehdi Dadashpour; Farhad Pouremamali; Mohammad Reza Sadeghi; Nasser Samadi; Narges Soozangar; Amir Mahdi Khamaneh
Journal:  Galen Med J       Date:  2019-01-25

Review 2.  Is Tissue Still the Issue? The Promise of Liquid Biopsy in Uveal Melanoma.

Authors:  Daniël P de Bruyn; Aaron B Beasley; Robert M Verdijk; Natasha M van Poppelen; Dion Paridaens; Ronald O B de Keizer; Nicole C Naus; Elin S Gray; Annelies de Klein; Erwin Brosens; Emine Kiliç
Journal:  Biomedicines       Date:  2022-02-21

Review 3.  MicroRNA Signature in Melanoma: Biomarkers and Therapeutic Targets.

Authors:  Soudeh Ghafouri-Fard; Mahdi Gholipour; Mohammad Taheri
Journal:  Front Oncol       Date:  2021-04-22       Impact factor: 6.244

4.  miR-370-3p Is a Therapeutic Tool in Anti-glioblastoma Therapy but Is Not an Intratumoral or Cell-free Circulating Biomarker.

Authors:  Arulraj Nadaradjane; Joséphine Briand; Gwenola Bougras-Cartron; Valentine Disdero; François M Vallette; Jean-Sébastien Frenel; Pierre-François Cartron
Journal:  Mol Ther Nucleic Acids       Date:  2018-09-13       Impact factor: 8.886

Review 5.  Rescue of TCA Cycle Dysfunction for Cancer Therapy.

Authors:  Jubert Marquez; Jessa Flores; Amy Hyein Kim; Bayalagmaa Nyamaa; Anh Thi Tuyet Nguyen; Nammi Park; Jin Han
Journal:  J Clin Med       Date:  2019-12-06       Impact factor: 4.241

Review 6.  One Omics Approach Does Not Rule Them All: The Metabolome and the Epigenome Join Forces in Haematological Malignancies.

Authors:  Antonia Kalushkova; Patrick Nylund; Alba Atienza Párraga; Andreas Lennartsson; Helena Jernberg-Wiklund
Journal:  Epigenomes       Date:  2021-10-08

Review 7.  MicroRNAs as Regulators of Cancer Cell Energy Metabolism.

Authors:  Natarajaseenivasan Suriya Muthukumaran; Prema Velusamy; Charles Solomon Akino Mercy; Dianne Langford; Kalimuthusamy Natarajaseenivasan; Santhanam Shanmughapriya
Journal:  J Pers Med       Date:  2022-08-18

8.  Emerging roles of circUBAP2 targeting miR-370-3p in proliferation, apoptosis, and invasion of papillary thyroid cancer cells.

Authors:  Hui Xiong; Jinsong Yu; Guangwei Jia; Yang Su; Jianliang Zhang; Qiu Xu; Xiaoxiong Sun
Journal:  Hum Cell       Date:  2021-08-03       Impact factor: 4.374

9.  Glutamate metabotropic receptor 4 (GRM4) inhibits cell proliferation, migration and invasion in breast cancer and is regulated by miR-328-3p and miR-370-3p.

Authors:  Bin Xiao; Daxiang Chen; Quan Zhou; Jianfeng Hang; Weiyun Zhang; Zhenzhan Kuang; Zhaohui Sun; Linhai Li
Journal:  BMC Cancer       Date:  2019-09-06       Impact factor: 4.430

10.  Circular RNA CircITGA7 Promotes Tumorigenesis of Osteosarcoma via miR-370/PIM1 Axis.

Authors:  Chuanwu Fang; Xiaohong Wang; Dongliang Guo; Run Fang; Ting Zhu
Journal:  Comput Math Methods Med       Date:  2020-09-10       Impact factor: 2.238

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.